Certain factors, such as age (≥ 60 years old), lymph node metastasis, TNM staging, differentiation type, and tumor recurrence, resulted in an upregulation of CD47 (p < 0.05). Here, CD47 is linked to metastatic malignant neoplasm in the lymph nodes.